Clinical Trials Browser

Phase 2 × Myelodysplastic Syndromes × Infusions, Intravenous × Clear all

NCT03238248 2024-11-04

Pevonedistat and Azacitidine in MDS or MDS/MPN Patients Who Fail Primary Therapy With DNA Methyl Transferase Inhibitors

Phase 2 Completed

71 enrolled 13 charts

Myelodysplastic Syndromes, Myeloproliferative Disorders